Maximus (MMS)
(Delayed Data from NYSE)
$80.43 USD
-0.20 (-0.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.90 +0.47 (0.58%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$80.43 USD
-0.20 (-0.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.90 +0.47 (0.58%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth B Momentum C VGM
Zacks News
Verisk (VRSK) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Verisk Analytics' (VRSK) first-quarter fiscal 2024 revenues are likely to have benefitted from growth in subscription revenues.
Equifax (EFX) Q1 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Equifax's (EFX) first-quarter 2024 revenues rise y/y due to improved segmental performances.
Should Value Investors Buy Maximus (MMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
Maximus (MMS) maintains solid relationships and a strong reputation with governments.
Why Is Maximus (MMS) Up 8.6% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Maximus (MMS) Stock Rises 9% Since Q1 Earnings Beat Estimates
by Zacks Equity Research
Maximus' (MMS) first-quarter fiscal 2024 earnings and revenues increase year over year.
Compared to Estimates, Maximus (MMS) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Insights Into Maximus (MMS) Q1: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Maximus (MMS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Booz Allen Hamilton (BAH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of 24.78% and 1.54%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Maximus (MMS) is an Attractive Pick Right Now
by Zacks Equity Research
Maximus (MMS) gains from diverse competitive advantages and shareholder-friendly policies.
Why Is Maximus (MMS) Up 1% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Retain Maximus (MMS) Stock in Your Portfolio Now
by Zacks Equity Research
Commitment to shareholder returns makes Maximus (MMS) a reliable way for investors to compound wealth over the long term.
Why You Should Hold Aptiv (APTV) Stock in Your Portfolio Now
by Zacks Equity Research
Aptiv's (APTV) smart architecture provides a competitive advantage and will likely help it continue gaining market share.
Reasons Why You Should Bet on Broadridge (BR) Stock Now
by Zacks Equity Research
Broadridge (BR) maintains a strong business model with substantial recurring revenue streams.
Maximus (MMS) Q4 Earnings Fall Short of Estimates, Decline Y/Y
by Zacks Equity Research
Maximus (MMS) fourth-quarter fiscal 2023 revenues increase 7.1% year over year.
Maximus (MMS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's Why Investors Should Bet on Xerox (XRX) Stock Now
by Zacks Equity Research
Xerox's (XRX) "Project Own It" is contributing significantly toward freeing up capital for investment.
Maximus (MMS) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Maximus' (MMS) fourth-quarter fiscal 2023 revenues are expected to have increased year over year.
Booz Allen Hamilton (BAH) Misses Q2 Earnings Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of -1.53% and 2.63%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks to Watch on Dividend Hikes Amid Market Volatility
by Ritujay Ghosh
Tanger Factory Outlet Centers, Inc. (SKT), Riley Exploration Permian, Inc. (REPX), EQT Corporation (EQT), MSC Industrial Direct Co., Inc. (MSM) and Maximus, Inc. (MMS) recently hiked dividends.
Booz Allen (BAH) Soars 3.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Booz Allen (BAH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Maximus (MMS) Stock Gains 32% in a Year: What You Should Know
by Zacks Equity Research
Maximus (MMS) has a solid track record of dividend payments.
Maximus (MMS) Up 1.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Retain Maximus (MMS) Stock in Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus (MMS) has grown to be a leading operator of government health and human services programs globally.
Maximus (MMS) Stock Declines 3.6% Since Q3 Earnings Miss
by Zacks Equity Research
Maximus' (MMS) third-quarter fiscal 2023 revenues increase year over year.